On the recordJuly 22, 2013
The reality is that these deals between brand-name and generic pharmaceutical companies delay the entry of generic medicines into the marketplace.
Source
congress.govEditor's note · Context
Grassley highlights how pay-for-delay deals postpone generic drug availability.
Share
More from Chuck Grassley
Jul 23, 2026
Caitlin is a generational talent. Her hard work and dedication should be rewarded, not penalized.
Jul 15, 2026
Maintaining the Department of Justice’s ability to protect Americans from crime and hold criminals accountable is essential for the safety of American families. I’ve worked well with Acting Attorney General Blanche for more than a year and…
Other voices in this conversation
